Advertisement

Cancer Immunology, Immunotherapy

, Volume 11, Issue 4, pp 243–250 | Cite as

Serologic analysis of human tumor antigens

III. Reactivity of patients with melanoma and osteogenic sarcoma to cultured tumor cells and fibroblasts in the immune adherence assay
  • Stephen F. Sener
  • John M. Brown
  • Cornelia L. Hyatt
  • William D. Terry
  • Steven A. Rosenberg
Original Articles
  • 17 Downloads

Summary

The immune adherence (IA) assay was used to measure serum reactivity of patients with melanoma and osteosarcoma against paired cell lines (tumor cells and normal skin fibroblasts obtained from the same individuals) grown in tissue culture. Sera from 224 patients with various stages of melanoma were compared with sera from 100 normal age- and sex-matched donors. None of the 18 stage I sera (0%), 23 of 166 (14%) stage II sera, 3 of 40 (7%) stage III sera, and 3 of 100 (3%) normal sera were highly reactive to a standard allogeneic melanoma-fibroblast pair. None of the sera exhibited unique activity against melanoma. There was no correlation between stage of melanoma and high serum reactivity, nor was this reactivity predictive of recurrence. Sera from 39 tumor-bearing osteosarcoma patients prior to amputation were compared with sera from 50 normal age-and sex-matched donors. Eight of 39 (21%) patient sera and 1 of 50 (2%) normal sera were highly reactive to an osteosarcoma-fibroblast pair. No sera had reactivity uniquely directed against osteosarcoma. Eight osteosarcoma and two melanoma patients were tested simultaneously against their autologous cultured tumor and skin cells. Only one of these patients exhibited high reactivity towards autologous cells, and this reactivity was equal against both osteosarcoma and normal cells. None of seven highly reactive osteosarcoma or six highly reactive melanoma sera had residual tumor-specific reactivity against allogeneic osteosarcoma or melanoma after absorption with cultured fibroblasts, cultured fetal fibroblasts, or fetal calf serum.

Keywords

Melanoma Osteosarcoma Tumor Antigen Melanoma Patient Skin Fibroblast 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Avrameas S, Ternynck T (1969) Cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents. Immunochemistry 6:53Google Scholar
  2. 2.
    Carey TE, Takahashi T, Resnick LA, Oettgen HF, Old LJ (1976) Cell surface antigens of human malignant melanoma: Mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci 73:3278Google Scholar
  3. 3.
    Catapano MS, Brown JM, Rosenberg SA (1980) Cytotoxic reactivity to cultured normal skin fibroblasts: Levels in sera from normal and sarcoma-bearing patients. Cancer Res 40:979Google Scholar
  4. 4.
    Cornain S, DeVries JE, Collard J, Vennegoor C, Van Wingerden I, Rumke P (1975) Antibodies and antigen expression in human melanoma detected by the immune adherence test. Int J Cancer 16:981Google Scholar
  5. 5.
    Irie RF, Irie K, Morton DL (1974) Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. J Natl Cancer Inst 52:1051Google Scholar
  6. 6.
    Irie RF, Irie K, Morton DL (1976) A membrane antigen common to human cancer and fetal brain tissues. Cancer Res 36:3510Google Scholar
  7. 7.
  8. 8.
    Lowry O, Rosebrough N, Farr NA, Randall R (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265PubMedGoogle Scholar
  9. 9.
    Nelson RAJ (1953) The immune adherence phenomenon: An immunological specific reaction between micro-organism and erythrocytes leading to enhanced phagocytosis. Science 118:733Google Scholar
  10. 10.
    Nishioka K, Irie RF, Kawana T, Takeuchi S (1969) Immunological studies on mouse mammary tumors. III. Surface antigens reacting with tumor-specific antibodies in immune adherence. Int J Cancer 4:139Google Scholar
  11. 11.
    Rosenberg SA (1977) Lysis of human normal and sarcoma cells in tissue culture by normal human serum: Implications for experiments in human tumor immunology. J Natl Cancer Inst 58:1233Google Scholar
  12. 12.
    Rosenberg SA, Tondreau SC, Shoffner PC, Hyatt CL, Brown JM, Thorpe W, Sindelar W (1979) Serologic analysis of human tumor antigens. II. Reactivity of sera from eleven osteogenic sarcoma patients against autologous and allogeneic tumor cells. Surgery 86:258Google Scholar
  13. 13.
    Rosenberg SA, Brown JM, Thorpe WP, Hyatt C, Shoffner P, Tondreau S (1980) Serologic studies of the antigens on human osteogenic sarcoma. In: Rosenberg SA (ed) Serologic analysis of human cancer antigens. Academic Press, New York, p 93Google Scholar
  14. 14.
    Saxton RE, Irie RF, Ferrone S, Pelligrino MA, Morton DL (1978) Establishment of paired tumor cells and autologous virus transformed cell lines to define humoral immune responses in melanoma and sarcoma patients. Int J Cancer 21:299Google Scholar
  15. 15.
    Seibert E, Sorg C, Happle R, Macher L (1977) Membrane-associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells. Int J Cancer 19:172Google Scholar
  16. 16.
    Shiku H, Takahashi T, Oettgen HF, Old LJ (1976) Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med 144:873Google Scholar
  17. 17.
    Shiku H, Takahashi T, Carey T, Resnick LA, Pfreundschuh M, Ueda R, Oettgen HF, Old LJ (1980) Definition of cell surface antigens of human malignant melanoma, astrocytoma, and renal cancer by typing with autologous serum. In: Rosenberg SA (ed) Serologic analysis of human cancer antigens. Academic Press, New York, p 305Google Scholar
  18. 18.
    Stern R, Wilczek J, Thorpe WP, Rosenberg SA, Cannon G (1980) Procollagens as markers for the cell of origin of human bone tumors. Cancer Res 40:325Google Scholar
  19. 19.
    Tachibana T, Klein E (1970) Detection of cell surface antigens on monolayer cells. I. The application of immune adherence in microscale. Immunology 19:771Google Scholar
  20. 20.
    Thorpe WP, Rosenberg SA (1979) Serologic analysis of human tumor antigens. I. Anti-sarcoma antibodies in the serum of patients with osteogenic sarcomas. J Natl Cancer Inst 62:1143Google Scholar
  21. 21.
    Thorpe WP, Parker G, Rosenberg SA (1977) Expression of fetal antigens by normal human skin cells grown in tissue culture. J Immunol 119:818Google Scholar
  22. 22.
    Thorpe W, Loeb W, Hyatt CL, Rosenberg SA (1979) Alkaline phosphatase measurements of paired normal and osteosarcoma tissue culture lines obtained from the same patient. Cancer Res 39:277Google Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • Stephen F. Sener
    • 1
  • John M. Brown
    • 1
  • Cornelia L. Hyatt
    • 1
  • William D. Terry
    • 2
  • Steven A. Rosenberg
    • 1
  1. 1.Surgery BranchNational Cancer Institute, National Institutes of HealthBethesdaUSA
  2. 2.Immunology BranchNational Cancer Institute, National Institutes of HealthBethesdaUSA

Personalised recommendations